Who
Gary J. Pruden
Director
Company insider
Files Form 4 as: Director, Lantheus Holdings; Director, Motus GI Holdings; Exec VP, WW Chair, Med Devices, Johnson & Johnson.
In numbers
- Trades disclosed
- 46
- Buys
- 2
- Sells
- 4
- Bought
- $275K
- Sold
- $4.4M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 7 Jun 2016
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —2,635 at $0.00 | filing |
| 15 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —2,635 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,543 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,537 at $0.00 | filing |
| 10 Jul 2024filed 12 Jul 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $1.2M12,530 at $95.04 | filing |
| 20 May 2024filed 22 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code G | —2,012 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,853 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,635 at $0.00 | filing |
| 5 Mar 2024filed 13 Mar 2024 | Motus GI Holdingsoption or derivative | SEC FORM 4 Code A | —23,205 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,798 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,012 at $0.00 | filing |
| 6 May 2022filed 12 May 2022 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,068 at $0.00 | filing |
| 6 May 2022filed 10 May 2022 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,616 at $0.00 | filing |
| 6 May 2022filed 10 May 2022 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,180 at $0.00 | filing |
| 10 Feb 2022filed 11 Feb 2022 | Motus GI Holdingsoption or derivative | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 5 Jan 2022filed 7 Jan 2022 | Motus GI Holdings | SEC FORM 4 Code A | —106,563 at $0.00 | filing |
| 10 May 2021filed 12 May 2021 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —8,513 at $0.00 | filing |
| 17 Feb 2021filed 19 Feb 2021 | Motus GI Holdings | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
Johnson & Johnson Announces a Lead Vaccine Candidate for COVID-19JNJ · equitybulls.com · 18 Oct 2026Johnson & Johnson Just Raised Its Sales Outlook Again. Here's Why the Dividend King Is Still a Buy.JNJ · fool.com · 17 Oct 2026Dividend Roundup: Johnson & Johnson, Coca-Cola, Costco, CVS Health, and moreJNJ · seekingalpha.com · 16 Oct 2026
0 headlines in the last 90 days name Gary J. Pruden; 3 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.